Skip to main content

Table 2 Relationships between PHR and clinical parameters

From: Association between the platelet/high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: results from NHANES 2017–2020

Variables

r

P value

Age

-0.190

 < 0.001

BMI

0.335

 < 0.001

TG

0.400

 < 0.001

TC

-0.084

 < 0.001

LDL-C

0.069

 < 0.001

ALT

0.119

 < 0.001

AST

-0.088

 < 0.001

GGT

0.128

 < 0.001

Alb

-0.095

 < 0.001

HbA1c

0.120

 < 0.001

CAP

0.277

 < 0.001

LSM

0.107

 < 0.001

ZJU index

0.383

 < 0.001

HSI

0.368

 < 0.001

FIB-4

-0.495

 < 0.001

NFS

-0.184

 < 0.001

  1. r Spearman’s correlation coefficient
  2. PHR Platelet/high-density lipoprotein cholesterol ratio, BMI Body mass index, TG Triglyceride, TC Total cholesterol, LDL-C Low-density lipoprotein cholesterol, ALT Alanine aminotransferase, AST Aspartate aminotransferase, GGT γ-glutamyltranspeptidase, Alb Albumin, HbA1c Glycosylated hemoglobin A1c, CAP Controlled attenuation parameter, LSM Liver stiffness measurement, NAFLD Nonalcoholic fatty liver disease, ZJU Index Zhejiang University index, HSI Hepatic steatosis index, FIB-4 Fibrosis-4, NFS Nonalcoholic fatty liver disease fibrosis score
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X